Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 256 AL 270

Neuroprotective Mechanisms of Salidroside in Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies

Zhang N, Nao J, Dong X.

J Agric Food Chem. 2023 Nov 22;71(46):17597-17614. doi: 10.1021/acs.jafc.3c06672. Epub 2023 Nov 7.

Gut microbiome-targeted therapies for Alzheimer's disease

Zhang T, Gao G, Kwok LY, Sun Z.

Gut Microbes. 2023 Dec;15(2):2271613. doi: 10.1080/19490976.2023.2271613. Epub 2023 Nov 7.

Current status of amyloid-targeting immunotherapies for Alzheimer's disease

Tabor GT, Holtzman DM.

Sci Transl Med. 2023 Nov 8;15(721):eadk9993. doi: 10.1126/scitranslmed.adk9993. Epub 2023 Nov 8.

Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer's disease

Zou D, Liu R, Lv Y, Guo J, Zhang C, Xie Y.

J Enzyme Inhib Med Chem. 2023 Dec;38(1):2270781. doi: 10.1080/14756366.2023.2270781. Epub 2023 Nov 13.

Oxygen metabolism abnormality and Alzheimer's disease: An update

Liu G, Yang C, Wang X, Chen X, Wang Y, Le W.

Redox Biol. 2023 Dec;68:102955. doi: 10.1016/j.redox.2023.102955. Epub 2023 Nov 8.

Targeting autophagy in Alzheimer's disease: Animal models and mechanisms

Zhang XW, Zhu XX, Tang DS, Lu JH.

Zool Res. 2023 Nov 18;44(6):1132-1145. doi: 10.24272/j.issn.2095-8137.2023.294.

What the Gantenerumab Trials Teach Us about Alzheimer's Treatment

Schneider LS.

N Engl J Med. 2023 Nov 16;389(20):1918-1920. doi: 10.1056/NEJMe2310903.

A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease

Faridar A, Eid AM, Thome AD, Zhao W, Beers DR, Pascual MB, Nakawah MO, Roman GC, Davis CS, Grundman M, Masdeu JC, Appel SH.

Transl Neurodegener. 2023 Nov 16;12(1):54. doi: 10.1186/s40035-023-00387-5.

[The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review]

Ishmuratova AN, Abramov MA, Kuznetsov KO, Ivanyuta MV, Shakirova ZF, Kitapova AI, Usmonov MD, Chernousova LM, Valeeva LI, Kuznetsova AY, Baislamov AS, Shaihetdinova AR, Mirgaliev AA, Orozberdiev ST, Yakupova KI.

Probl Endokrinol (Mosk). 2023 Nov 11;69(5):73-83. doi: 10.14341/probl13183.

The Neuropathological Impacts of COVID-19: Challenges and Alternative Treatment Options for Alzheimer's Like Brain Changes on Severely SARS-CoV-2 Infected Patients

Rahman MR, Akter R, Neelotpol S, Mayesha II, Afrose A.

Am J Alzheimers Dis Other Demen. 2023 Jan-Dec;38:15333175231214974. doi: 10.1177/15333175231214974.

Advances in amyloid-targeting monoclonal antibodies for Alzheimer's disease: clinical and public health issues

Salemme S, Ancidoni A, Locuratolo N, Piscopo P, Lacorte E, Canevelli M, Vanacore N.

Expert Rev Neurother. 2023 Jul-Dec;23(12):1113-1129. doi: 10.1080/14737175.2023.2284305. Epub 2023 Dec 15.

[Mindfulness meditation and art therapy for Alzheimer's patients and their caregivers]

Filleau C, Febvre-Richards E, Konig A, Fabre R, Mouton A, Sacco G.

Soins Gerontol. 2023 Nov-Dec;28(164):27-34. doi: 10.1016/j.sger.2023.09.008. Epub 2023 Oct 17.

NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer's Disease

Tao S, Fan W, Liu J, Wang T, Zheng H, Qi G, Chen Y, Zhang H, Guo Z, Zhou F.

J Alzheimers Dis. 2023;96(4):1383-1398. doi: 10.3233/JAD-230567.

Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial

Fernando MG, Silva R, Fernando WMADB, de Silva HA, Wickremasinghe AR, Dissanayake AS, Sohrabi HR, Martins RN, Williams SS.

J Alzheimers Dis. 2023;96(3):1195-1206. doi: 10.3233/JAD-230670.

UNVEILING THE COMPLEX ROLE OF NF-ΚB IN ALZHEIMER'S DISEASE: INSIGHTS INTO BRAIN INFLAMMATION AND POTENTIAL THERAPEUTIC TARGETS

Verma Y, Sachdeva H, Kalra S, Kumar P, Singh G.

Georgian Med News. 2023 Sep;(342):133-141.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias